2024-03-14 08:45:00
Dicot continues to stay on schedule in its clinical phase I study. In January, the company, which is developing the next generation of potency drugs, was able to make a first positive data reading from the study, and now the last participant in the trial has been recruited.
Read the full article at biostock.se (https://www.biostock.se/en/):
https://www.biostock.se/en/2024/03/dicots-phase-i-study-fully-recruited/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se